Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus

View original at finance.yahoo.com
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus Major U.S. indexes like the Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average rallied 2.4%, 1.8%, and 1.3%, respectively, during holiday-shortened trading last week…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Zacks Focus List portfolio returned +22.1% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for equal-weight version

    80% confidence
  • Equal-weight portfolio of Zacks Rank #1 stocks outperformed the equal-weight S&P 500 index by 7 percentage points (+17.81% vs. +10.85%)

    80% confidence
  • Zacks ECAP returned -1.67% for full year 2025 vs. S&P 500's +17.9% gain

    80% confidence
  • Zacks Focus List portfolio returned -15.2% in 2022 vs. S&P 500's -17.96%

    80% confidence
  • Zacks ECDP returned -2.1% in Q4 2025 vs. S&P 500's +2.7% gain and NOBL's +1.6% return

    80% confidence
  • Fresh tariff threats to countries opposing acquisition of Greenland

    80% confidence
  • Zacks ECAP returned +16.26% in 2024 vs. +24.89% for S&P 500

    80% confidence
  • Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for S&P 500 and +13% for equal-weight S&P 500

    80% confidence
  • Zacks Top 10 portfolio returned +22.6% in 2025 vs. +17.9% for S&P 500 and +11.4% for equal-weight version

    80% confidence
  • Hypothetical equal-weight portfolio returned +22.4% in 2024 vs. +13.7% for the equal-weight S&P 500 index

    80% confidence
  • Over 10-year period (2016-2025), equal-weight Zacks Rank #1 stocks portfolio outperformed equal-weight S&P 500 by more than 7 percentage points (+18.55% vs. +11.65%)

    80% confidence
  • Zacks ECDP returned -0.6% in 2025 vs. +6.8% for NOBL

    80% confidence
  • Since 2012, Top 10 portfolio produced cumulative return of +2,472.7% vs. +561.6% for S&P 500 and +403.3% for equal-weight version

    80% confidence
  • Top 10 portfolio produced average annual return of +25.8% from 2012 through 2025 vs. +13.1% for S&P 500 and +10.5% for equal-weight version

    80% confidence
  • Zacks Top 10 portfolio returned +62.98% in 2024 vs. +25.04% for S&P 500 and +13% for equal-weight version

    80% confidence
  • Zacks Focus List portfolio returned +29.54% in 2023 vs. +26.28% for S&P 500 and +13.61% for equal-weight S&P 500

    80% confidence
  • Zacks ECAP portfolio returned -2.3% in Q4 2025 vs. S&P 500's +2.7% gain

    80% confidence
  • Suggested a collaborative framework for Greenland during World Economic Forum at Davos summit

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus — Source | Via News | ViaNews Market